Login / Signup

Inhibition of receptor interacting protein kinase-1 (RIPK1) in the treatment of murine lupus.

Lin PengPengcheng WangXiaodong XuDacheng ChenFeng XuFan YangShuying YangHongguang XiaZhi-Hong LiuWeisong Qin
Published in: Lupus science & medicine (2024)
RIPK1 inhibition has a protective effect in the mouse model of SLE and can potentially become a new therapeutic target for SLE in humans.
Keyphrases
  • systemic lupus erythematosus
  • protein kinase
  • disease activity
  • mouse model
  • rheumatoid arthritis
  • binding protein